Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,729 | -15,204 | -11,108 | -20,963 | -30,544 |
| Depreciation Amortization | 428 | 294 | 171 | 284 | 284 |
| Other Working Capital | -427 | -2,129 | 2,001 | 1,893 | -93 |
| Other Operating Activity | 8,153 | -4,988 | -3,839 | 12,330 | 12,070 |
| Operating Cash Flow | $-28,575 | $-22,027 | $-12,775 | $-6,456 | $-18,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72 | -50 | -26 | -6 | -12 |
| Investing Cash Flow | $-72 | $-50 | $-26 | $-6 | $-12 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -527 | -369 | -212 | -496 | -496 |
| Dividend Paid | -1,095 | -1,095 | -1,095 | N/A | N/A |
| Other Financing Activity | 46,710 | 46,187 | 46,187 | 46,187 | 28,037 |
| Financing Cash Flow | $45,088 | $44,723 | $44,880 | $45,691 | $27,541 |
| Beginning Cash Position | 9,701 | 9,701 | 9,701 | 9,701 | 455 |
| End Cash Position | 26,142 | 32,347 | 41,780 | 48,930 | 9,701 |
| Net Cash Flow | $16,441 | $22,646 | $32,079 | $39,229 | $9,246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,575 | -22,027 | -12,775 | -6,456 | -18,283 |
| Capital Expenditure | -72 | -50 | -26 | -6 | -12 |
| Free Cash Flow | -28,647 | -22,077 | -12,801 | -6,462 | -18,295 |